title: The rational use of psychotropic drugs in pregnancy and postpartum.
abstract: When a pregnant woman or nursing mother requires psychotropic medication, one must consider the effect of such medications on the fetus or baby. The authors review the evidence for teratogenic effects of such drugs given during pregnancy, toxic or withdrawal effects in the newborn and dangers to the breast-fed baby. Suggestions are made for judicious use of psychotropic drugs in pregnant or nursing women.
authors.forename: G E
authors.initials: GE
authors.lastname: Robinson
authors.forename: D E
authors.initials: DE
authors.lastname: Stewart
authors.forename: E
authors.initials: E
authors.lastname: Flak
mesh_terms: D000014:Abnormalities, Drug-Induced; D014151:Anti-Anxiety Agents / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D001942:Breast Feeding; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008094:Lithium / Q000009:adverse effects; D001523:Mental Disorders / Q000188:drug therapy*; D007744:Obstetric Labor Complications / Q000139:chemically induced; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011297:Prenatal Exposure Delayed Effects; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D011644:Puerperal Disorders / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome
chemical_list: D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D011619:Psychotropic Drugs; D008094:Lithium